Evidence map›Paper›PMID 37029391›Full record

ArticleMolecular autism2023

The activation of mGluR4 rescues parallel fiber synaptic transmission and LTP, motor learning and social behavior in a mouse model of Fragile X Syndrome.

Ricardo Martín, Alberto Samuel Suárez-Pinilla, Nuria García-Font, M Luisa Laguna-Luque, Juan C López-Ramos, María Jesús Oset-Gasque, Agnes Gruart, José M Delgado-García, Magdalena Torres, José Sánchez-Prieto

Open access · goldAbstract read
In one paragraph

Article in Molecular autism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Cage effects on synaptic plasticity and its modulation in a mouse model of fragile X syndrome.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  3. Article
  4. Calcium-Dependent Regulation of Neuronal Excitability Is Rescued in Fragile X Syndrome by a Tat-Conjugated N-Terminal Fragment of FMRP.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Epigenetic insights into Fragile X Syndrome.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ricardo Martín *Departamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Universidad Complutense, Instituto Universitario de Investigación en Neuroquímica, 28040, Madrid, Spain. rmartinh@ucm.es.
Alberto Samuel Suárez-Pinilla *Departamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Universidad Complutense, Instituto Universitario de Investigación en Neuroquímica, 28040, Madrid, Spain.
Nuria García-Font *Departamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Universidad Complutense, Instituto Universitario de Investigación en Neuroquímica, 28040, Madrid, Spain.
M Luisa Laguna-LuqueDivision de Neurociencias, Universidad Pablo de Olavide, 41013, Sevilla, Spain.
Juan C López-RamosDivision de Neurociencias, Universidad Pablo de Olavide, 41013, Sevilla, Spain.
María Jesús Oset-GasqueInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, 28040, Madrid, Spain.
Agnes GruartDivision de Neurociencias, Universidad Pablo de Olavide, 41013, Sevilla, Spain.
José M Delgado-GarcíaDivision de Neurociencias, Universidad Pablo de Olavide, 41013, Sevilla, Spain.
Magdalena TorresDepartamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Universidad Complutense, Instituto Universitario de Investigación en Neuroquímica, 28040, Madrid, Spain.
José Sánchez-PrietoDepartamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Universidad Complutense, Instituto Universitario de Investigación en Neuroquímica, 28040, Madrid, Spain. jsprieto@ucm.es.
Universidad Complutense de Madrid · ESUniversidad Pablo de Olavide · ES

Funding

Comunidad de Madrid B2017/BMD-3688Instituto de Salud Carlos III RD 16/0019/0009Junta de Andalucía PY18-82Ministerio de Ciencia e Innovación PRE2018-083202Ministerio de Economía y Competitividad BFU 2017-83292-R
6 · The paper itself

Abstract

backgroundFragile X syndrome (FXS), the most common inherited intellectual disability, is caused by the loss of expression of the Fragile X Messenger Ribonucleoprotein (FMRP). FMRP is an RNA-binding protein that negatively regulates the expression of many postsynaptic as well as presynaptic proteins involved in action potential properties, calcium homeostasis and neurotransmitter release. FXS patients and mice lacking FMRP suffer from multiple behavioral alterations, including deficits in motor learning for which there is currently no specific treatment.

methodsWe performed electron microscopy, whole-cell patch-clamp electrophysiology and behavioral experiments to characterise the synaptic mechanisms underlying the motor learning deficits observed in Fmr1KO mice and the therapeutic potential of positive allosteric modulator of mGluR4.

resultsWe found that enhanced synaptic vesicle docking of cerebellar parallel fiber to Purkinje cell Fmr1KO synapses was associated with enhanced asynchronous release, which not only prevents further potentiation, but it also compromises presynaptic parallel fiber long-term potentiation (PF-LTP) mediated by β adrenergic receptors. A reduction in extracellular Ca LIMITATIONS: We cannot rule out that the activation of mGluR4s via systemic administration of VU0155041 can also affect other brain regions. Further studies are needed to stablish the effect of a specific activation of mGluR4 in cerebellar granule cells.

conclusionsOur study shows that an increase in synaptic vesicles, SV, docking may cause the loss of PF-LTP and motor learning and social deficits of Fmr1KO mice and that the reversal of these changes by pharmacological activation of mGluR4 may offer therapeutic relief for motor learning and social deficits in FXS.

Indexed as

Fragile X SyndromeLong-Term PotentiationAnilidesAnimalsCyclohexanecarboxylic AcidsDisease Models, AnimalFragile X Messenger Ribonucleoprotein 1MaleMiceMice, KnockoutReceptors, Metabotropic GlutamateSocial BehaviorSynaptic TransmissionAnilidesCyclohexanecarboxylic AcidsFragile X Messenger Ribonucleoprotein 1metabotropic glutamate receptor 4Receptors, Metabotropic GlutamateVU 0155041Classical conditioningFmr1 KOParallel fiber-Purkinje cell synapseRRP sizeVestibuloocular reflexβ adrenergic receptor

Identifiers

PMID37029391
PMCPMC10082511
OpenAlexW4362703336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.